Cargando…

141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes

BACKGROUND: Viruses and bacteria are important contributors to asthma exacerbations. Exercise at competitive level is believed to increase susceptibility to respiratory infections. The study aimed at investigation of the anti-infectious immune response in athletes in the context of exercise intensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurowski, Marcin, Jurczyk, Janusz, Jarzebska, Marzanna, Moskwa, Sylwia, Makowska, Joanna S., Krysztofiak, Hubert, Kowalski, Marek L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513113/
http://dx.doi.org/10.1097/01.WOX.0000411886.44524.d9
_version_ 1782251878792298496
author Kurowski, Marcin
Jurczyk, Janusz
Jarzebska, Marzanna
Moskwa, Sylwia
Makowska, Joanna S.
Krysztofiak, Hubert
Kowalski, Marek L.
author_facet Kurowski, Marcin
Jurczyk, Janusz
Jarzebska, Marzanna
Moskwa, Sylwia
Makowska, Joanna S.
Krysztofiak, Hubert
Kowalski, Marek L.
author_sort Kurowski, Marcin
collection PubMed
description BACKGROUND: Viruses and bacteria are important contributors to asthma exacerbations. Exercise at competitive level is believed to increase susceptibility to respiratory infections. The study aimed at investigation of the anti-infectious immune response in athletes in the context of exercise intensity, atopy and allergic diseases. METHODS: Questionnaire data were obtained from 219 Polish athletes (median age 26 years) preparing for Beijing Olympic Games during the multicenter study within the GA(2)LEN project (WP 2.8.2). Allergy Questionnaire for Athletes (AQUA) (Bonini et al 2009) was used to obtain data about symptoms and exercise pattern. Athletes were evaluated by allergist. Control group consisted of 77 healthy never-smokers (median age 29 years) not performing sport at competitive level. Serum IgG against parainfluenza virus 1,2 and 3 (PIV), respiratory syncytial virus (RSV), adenovirus and Mycoplasma pneumoniae were determined by ELISA. RESULTS: Percentage of athletes with positive serological testing was lower than percentage of HC in case of PIV (P < 0.0003), RSV (P = 0.01) and M. pneumoniae (P = 0.01). Analysis of IgG only in subjects with positive testing showed lower anti-PIV IgG levels in non-atopic athletes compared to HC (P < 0.001) and atopic athletes (P < 0.01) (median 66.0 vs 104.8 and 88.1 U/mL). In contrast, higher adenovirus IgG titres were found in atopic and non-atopic athletes as compared to HC (52.3 and 48.5 vs 36.6 EIU, P < 0.001). Positive anti-PIV serology test was most frequent in athletes with allergic rhinitis compared to asthmatic and healthy athletes (78.3 vs 50.0 and 46.8%; P = 0.002). For PIV and M. pneumoniae the difference was also seen when atopic and non-atopic athletes were compared separately with HC. Positive RSV serology was more frequent in atopic versus non-atopic athletes (76.3 vs 60.8%, P = 0.03) and in HC versus non-atopic athletes (84.4 vs 60.8%, P = 0.001) but no significant difference between atopic athletes and HC was seen. Positive RSV serology was associated with atopy (OR 2.89; 95% CI, 1.34-6.23; P = 0.007). No differences were observed with regard to exercise pattern (endurance vs non-endurance). CONCLUSIONS: Competitive sport at Olympic level may be associated with altered immune response against respiratory pathogens. For some agents this response may be affected by the atopic status.
format Online
Article
Text
id pubmed-3513113
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35131132012-12-21 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes Kurowski, Marcin Jurczyk, Janusz Jarzebska, Marzanna Moskwa, Sylwia Makowska, Joanna S. Krysztofiak, Hubert Kowalski, Marek L. World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Viruses and bacteria are important contributors to asthma exacerbations. Exercise at competitive level is believed to increase susceptibility to respiratory infections. The study aimed at investigation of the anti-infectious immune response in athletes in the context of exercise intensity, atopy and allergic diseases. METHODS: Questionnaire data were obtained from 219 Polish athletes (median age 26 years) preparing for Beijing Olympic Games during the multicenter study within the GA(2)LEN project (WP 2.8.2). Allergy Questionnaire for Athletes (AQUA) (Bonini et al 2009) was used to obtain data about symptoms and exercise pattern. Athletes were evaluated by allergist. Control group consisted of 77 healthy never-smokers (median age 29 years) not performing sport at competitive level. Serum IgG against parainfluenza virus 1,2 and 3 (PIV), respiratory syncytial virus (RSV), adenovirus and Mycoplasma pneumoniae were determined by ELISA. RESULTS: Percentage of athletes with positive serological testing was lower than percentage of HC in case of PIV (P < 0.0003), RSV (P = 0.01) and M. pneumoniae (P = 0.01). Analysis of IgG only in subjects with positive testing showed lower anti-PIV IgG levels in non-atopic athletes compared to HC (P < 0.001) and atopic athletes (P < 0.01) (median 66.0 vs 104.8 and 88.1 U/mL). In contrast, higher adenovirus IgG titres were found in atopic and non-atopic athletes as compared to HC (52.3 and 48.5 vs 36.6 EIU, P < 0.001). Positive anti-PIV serology test was most frequent in athletes with allergic rhinitis compared to asthmatic and healthy athletes (78.3 vs 50.0 and 46.8%; P = 0.002). For PIV and M. pneumoniae the difference was also seen when atopic and non-atopic athletes were compared separately with HC. Positive RSV serology was more frequent in atopic versus non-atopic athletes (76.3 vs 60.8%, P = 0.03) and in HC versus non-atopic athletes (84.4 vs 60.8%, P = 0.001) but no significant difference between atopic athletes and HC was seen. Positive RSV serology was associated with atopy (OR 2.89; 95% CI, 1.34-6.23; P = 0.007). No differences were observed with regard to exercise pattern (endurance vs non-endurance). CONCLUSIONS: Competitive sport at Olympic level may be associated with altered immune response against respiratory pathogens. For some agents this response may be affected by the atopic status. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3513113/ http://dx.doi.org/10.1097/01.WOX.0000411886.44524.d9 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Kurowski, Marcin
Jurczyk, Janusz
Jarzebska, Marzanna
Moskwa, Sylwia
Makowska, Joanna S.
Krysztofiak, Hubert
Kowalski, Marek L.
141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title_full 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title_fullStr 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title_full_unstemmed 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title_short 141 Abnormal Immune Response Against Respiratory Pathogens in Olympic Athletes
title_sort 141 abnormal immune response against respiratory pathogens in olympic athletes
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513113/
http://dx.doi.org/10.1097/01.WOX.0000411886.44524.d9
work_keys_str_mv AT kurowskimarcin 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT jurczykjanusz 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT jarzebskamarzanna 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT moskwasylwia 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT makowskajoannas 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT krysztofiakhubert 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes
AT kowalskimarekl 141abnormalimmuneresponseagainstrespiratorypathogensinolympicathletes